ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,982.72
-0.84%
US Tech 100
21,112.40
-1.21%
Dow Jones
42,215.80
-0.70%
Brent Oil
75.205
-1.10%
Bitcoin
105,456.06
0.82%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aurinia Pharmaceuticals Inc (AUPH) Quote

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (AUPH)

NASDAQ
7.91
-0.23
(-2.83%)
Closed June 18 4:00PM
15 min delayed - Upgrade to Realtime
7.91
0.00
(0.00%)
After Hours: 7:58PM
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
7.91
Bid
7.90
Ask
8.03
Volume
935,130
7.91 Day's Range 8.13
5.195 52 Week Range 10.67
Market Cap
1.131B
Previous Close
8.14
Open
8.09
Last Trade
2
@
7.9
Last Trade Time
Financial Volume
$ 7,498,504
VWAP
8.0187
Average Volume (3m)
1,222,275
Shares Outstanding
142,990,974
Dividend Yield
-
PE Ratio
196.77
Earnings Per Share (EPS)
0.04
Revenue
239.48M
Net Profit
5.75M

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FS... Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.auriniapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
-
Aurinia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AUPH. The last closing price for Aurinia Pharmaceuticals was $8.14. Over the last year, Aurinia Pharmaceuticals shares have traded in a share price range of $ 5.195 to $ 10.67.

Aurinia Pharmaceuticals currently has 142,990,974 shares outstanding. The market capitalization of Aurinia Pharmaceuticals is $1.16 billion. Aurinia Pharmaceuticals has a price to earnings ratio (PE ratio) of 196.77.

Ask ADVFN Intelligence (AI)

AUPH Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 12 2025
AUPH (-2.83%)

Form 8-K - Current report
Edgar (US Regulatory)
May 12 2025
AUPH (-2.83%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 17 2025
AUPH (-2.83%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.22-2.706027060278.138.3157.98998658.15946398CS
4-0.14-1.739130434788.058.57997.7711314648.11197798CS
12-0.61-7.159624413158.528.736.82512222758.00434368CS
26-1.685-17.56122980729.5959.766.5513116928.10789587CS
522.340.99821746885.6110.675.19513137157.55829767CS
156-2.06-20.66198595799.9712.64.0720268338.10823062CS
260-8.26-51.082251082316.1733.97154.07247955312.24090827CS

AUPH - Frequently Asked Questions (FAQ)

What is the current Aurinia Pharmaceuticals share price?
The current share price of Aurinia Pharmaceuticals is $ 7.91
How many Aurinia Pharmaceuticals shares are in issue?
Aurinia Pharmaceuticals has 142,990,974 shares in issue
What is the market cap of Aurinia Pharmaceuticals?
The market capitalisation of Aurinia Pharmaceuticals is USD 1.16B
What is the 1 year trading range for Aurinia Pharmaceuticals share price?
Aurinia Pharmaceuticals has traded in the range of $ 5.195 to $ 10.67 during the past year
What is the PE ratio of Aurinia Pharmaceuticals?
The price to earnings ratio of Aurinia Pharmaceuticals is 196.77
What is the cash to sales ratio of Aurinia Pharmaceuticals?
The cash to sales ratio of Aurinia Pharmaceuticals is 4.72
What is the reporting currency for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Aurinia Pharmaceuticals?
The latest annual turnover of Aurinia Pharmaceuticals is USD 239.48M
What is the latest annual profit for Aurinia Pharmaceuticals?
The latest annual profit of Aurinia Pharmaceuticals is USD 5.75M
What is the registered address of Aurinia Pharmaceuticals?
The registered address for Aurinia Pharmaceuticals is 1203-4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8
What is the Aurinia Pharmaceuticals website address?
The website address for Aurinia Pharmaceuticals is www.auriniapharma.com
Which industry sector does Aurinia Pharmaceuticals operate in?
Aurinia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 19.92
(190.04%)
57.35M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.39M
EYENEyenovia Inc
$ 6.96
(134.34%)
29.94M
RBNERobin Energy Ltd
$ 10.60
(92.03%)
45.44M
RELIReliance Global Group Inc
$ 2.20
(86.44%)
19.29M
SDSTStardust Power Inc
$ 0.186
(-52.10%)
39.42M
SHOTWSafety Shot Inc
$ 0.0161
(-45.97%)
12.35k
RUNSunrun Inc
$ 5.78
(-40.04%)
120.05M
SEDGSolarEdge Technologies Inc
$ 15.94
(-33.53%)
33.14M
GOVXGeoVax Labs Inc
$ 0.8924
(-32.39%)
2.64M
PCSAProcessa Pharmaceuticals Inc
$ 0.2632
(16.93%)
575.5M
GNLNGreenlane Holdings Inc
$ 0.0104
(-16.13%)
392.94M
HCTIHealthcare Triangle Inc
$ 0.022
(-16.67%)
356.57M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.39M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.9373
(-7.75%)
143.55M

AUPH Discussion

View Posts
cervelo cervelo 10 hours ago
since this stock will never be worth more than 8.00 as long a pete is the ceo I would
settle seeing pete in jail for being the bernie madoff of AUPH.
👍️0
cervelo cervelo 10 hours ago
since this stock will never be worth more than 8.00 as long a pete is the ceo I would
settle seeing pete in jail for being the bernie madoff of AUPH.
👍️0
rosemountbomber rosemountbomber 1 day ago
You are righf about that, but to fair L's uptake no where resembles a hockey stick.  1st qtr pretax profit of 24 million. Doesn't Pete make more than that.  Should have been sold before demonstrating how difficult it is to sell the drug. 
👍️0
Pablo Bio Pablo Bio 1 day ago
AUPH!! Like Rodney Dangerfield would say, AUPH gets no respect,
👍️0
cervelo cervelo 1 week ago
Funny, His wife made the same comment,
👍 1
biotech_researcher biotech_researcher 1 week ago
Don't listen to the doubters, Pete's got the goods and will deliver the prize to your brokerage accounts.. He starts slow, but finishes strong. Like Glickman...
👍️0
cervelo cervelo 3 weeks ago
the market seems to be growing and pete is just leaving us behind.
for some reason this crook believes this is his private company he started, with his own money and owes no one a any reasoning as to why he is so ill prepared to be a ceo.
I do not think this is about market growth just a free paycheck
👍️0
biotech_researcher biotech_researcher 1 month ago
This is all about the growth rate of this market. Folks, this isn't a new cancer drug....
👍️0
biotech_researcher biotech_researcher 1 month ago
I think, heck I know, Pete's team that recruited him for the position did a terrific job, and were handsomely rewarded for their efforts.. well done, Pete.
👍️ 1
Fangster Fangster 1 month ago
@biotech researcher:  I'm certainly not the person to offer self help advice.  However, Cervelo is 💯right.  Greenleaf has failed AUPH and shareholders.  He's also correct, the guy is grossly overpaid and deserving of a substantial pay cut if he manages to hang on here. 
A quality mgmt team would have this trading at 20+ without a buyout.   The company needs a large disrupter shareholder to apply pressure for a management shakeup.  
👍️0
cervelo cervelo 1 month ago
lol

surely you don't think paying pettie another 10 million plus for another year will make a value towards shareholder value. I am dropping my expectations down to 10.50 to get out to many companies out there where a return on investment is possible. auph stock is like driving to idaho to buy a lottery ticket and think something will happen. though a lottery ticket may just have a better chance than we do here.
👍️0
biotech_researcher biotech_researcher 1 month ago
Cervelo, for your well being, please step away from the board for two months. I promise you that you will be a new man, with an incredible future..
👍 1
cervelo cervelo 1 month ago
some people love to wake up to the smell of fresh coffee in the morning

not me I wake up to enjoy the burning of good money, keep up the good work smokey the bearpete
👍️0
cervelo cervelo 1 month ago
Great run on upbeat earnings.

the market does not care about auph as long as pettie is making 20 times what the president gets paid.
👍️ 1
biotech_researcher biotech_researcher 1 month ago
Great call. Buy back. Cashflow great. Profitability. Congratulations Jess.
👍️0
Whalatane Whalatane 1 month ago
Is Lupy sold outside the US ? Trump wants to match the lowest price paid on drug outside the US
President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more than people in countries that have the lowest price.


Earnings release tomorrow ...another attempt by mgt to justify their ridiculous pricing ?
Kiwi
👍️0
rosemountbomber rosemountbomber 1 month ago
Is the executive order coming out tomorrow that is supposed to drop US drug prices by 30% to 80% gonna tank pharma/bio stocks?  When the gov sees the margin on Lupy their eyes will light up. 
👍️0
cervelo cervelo 1 month ago
Kind of like pelosi, vote for the bill and you can read it later, "Trust us"
👍️ 2
Zeppo Zeppo 1 month ago
Annual Meetings usually allow shareholders to attend in person. This group obviously doesn't want to hear "it", so it's being done only in a virtual format.
👍️0
biotech_researcher biotech_researcher 1 month ago
https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/348/iss-recommends-that-aurinia-shareholders-vote-for-all
👍️0
biotech_researcher biotech_researcher 2 months ago
Pete's got this..
👍️0
cervelo cervelo 2 months ago
He is what a 10.6 million dollar gets you in a crooked ceo

“When Glass Lewis first recommended a proxy stance for Aurinia on June 19, 2019, Aurinia’s market capitalization was approximately $1.84 billion, and its enterprise value was about $1.665 billion. As of April 30, 2025, the market capitalization is $1.114 billion, and the enterprise value is $765.3 million, representing declines of 39.5% and 54.0%, respectively.”


don't even want to think of it adjusted with inflation
👍️0
cervelo cervelo 2 months ago
remember vote early and often, a vote for petie is a vote for the same nothingness. 10 million a year pay package and only his middle finger has been lifted towards the shareholders
👍️0
nsomniyak nsomniyak 2 months ago
Got my proxies today.

I voted yes for Tang, no on all the other directors, yes on the auditor, yes on "say for pay", and no on increasing the pool of shares for stock compensation.
👍️ 2
Jesspro Jesspro 2 months ago
Time is still on their side, almost 12 more years of patent exclusivity. It will Cerv. Let’s forget our banters. We’re all rooting for the stuff, profit.
👍️0
cervelo cervelo 2 months ago
thank you, still waiting to see if auph gets resurrected.
👍️0
Jesspro Jesspro 2 months ago
Cervelo, belated happy Easter.
👍️0
cervelo cervelo 2 months ago
fools and their money are soon parted.


some people may be riding on free shares from the crooked ceo
👍️0
biotech_researcher biotech_researcher 2 months ago
I have no doubt that Pete has got this guy on speed dial:https://finance.yahoo.com/news/alis-biosciences-launches-fund-free-070000220.html
👍️0
biotech_researcher biotech_researcher 2 months ago
Remember, Jess said he will still be here even if it drops to $2.
👍️0
cervelo cervelo 2 months ago
this part is a joke!
We have redesigned our employee equity incentive program to strengthen its alignment with shareholder interests.

petie has never done anything that is linked to shareholder interests,
all he had done is steal the shareholders funds
👍️ 1
biotech_researcher biotech_researcher 2 months ago
Jess will be pleased:https://d1io3yog0oux5.cloudfront.net/auriniapharma/sec/0001600620-25-000032/0001600620-25-000032.pdf
👍️0
derkleineprinz derkleineprinz 2 months ago
...what do you expect regarding a buyout?
👍️0
biotech_researcher biotech_researcher 2 months ago
I know Ariad, and I know Aurinia. Aurinia is no Ariad..
👍 1
cervelo cervelo 3 months ago
insiders may buy, yet the real crook sells
PETER GREENLEAF (Chief Executive Officer) has made 0 purchases and 2 sales selling 360,540 shares for an estimated $2,871,124.
He probably has never paid for any shares of this company he is just a worthless boat anchor. From 34.00+ stock, petie can't even get it up to 12.5 so I can run
👍️0
nsomniyak nsomniyak 3 months ago
I wish some insider would buy out PG's employment contract...
👍️0
Jesspro Jesspro 3 months ago
Total Value of Insider Purchases In March: $9.58 million
👍️0
biotech_researcher biotech_researcher 3 months ago
Clackson was truly the champion. Berger was a liability..
👍️0
puravida puravida 3 months ago
nice to see a bunch of ARIAD warriors still here. Miss you all I don't use this site that much anymore. Let's relive the glory days of the great Harvey Berger and when Rachel McMinn the analyst hung up on him on the earnings call and issued a $1 PT. LOL. Timmy clackson for the win folks. We knew Brigatinib was a winner take care
👍 1
cervelo cervelo 3 months ago
Going at it like a real company. Unlike pete going at it like shareholder funds are his personal savings account. Still wonder what pete does to justify paying himself over 20 times what the president of the USA gets.
👍️0
biotech_researcher biotech_researcher 3 months ago
https://www.nephjc.com/news/regency-obi-ln-prnn2?ss_source=sscampaigns&ss_campaign_id=67d06f559c06ee20d3c67e57&ss_email_id=67d089d74377ed4b2ba194c2&ss_campaign_name=Do+we+have+another+lupus+medication+in+our+arsenal?&ss_campaign_sent_date=2025-03-11T19:07:12Z
👍 1
biotech_researcher biotech_researcher 3 months ago
NephJC ChatTuesday, March 11, 2025,  9 pm Eastern on BlueskyN Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2410965. Online ahead of print.Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard A Furie, Brad H Rovin, Jay P Garg, Mittermayer B Santiago, Gustavo Aroca-Martínez, Adolfina Elizabeth Zuta Santillán, Damaris Alvarez, Cleyber Navarro Sandoval, Alexander M Lila, James A Tumlin, Amit Saxena, Fedra Irazoque Palazuelos, Harini Raghu, Bongin Yoo, Imran Hassan, Elsa Martins, Himanshi Sehgal, Petra Kirchner, Jorge Ross Terres, Theodore A Omachi, Thomas Schindler, William F Pendergraft 3rd, Ana Malvar; REGENCY Trial InvestigatorsPMID: 39927615



👍️0
cervelo cervelo 3 months ago
Spike today looks normal. tang buys price goes up, dishonest ceo price goes back down.
I guess 10 million a year is not enough for the crook he has to sell shares he awarded himself for free for a extra 3 million.
guess peetie needed moer vacation money since he is obviously doing nothing for the company, patients, or share holder value like he said he was going to do.
Maybe when the next vote comes due share holders will awaken and vote off the complete board save tang and run peetie out of town. then again he will say circumstances will not allow him to step down until the company bank account is emptied.
👍️ 1
sonicty28 sonicty28 3 months ago
More Tang share purchases, means a BO can't happen soon I imagine because he is an insider but maybe a takeover by him
👍️0
Jesspro Jesspro 3 months ago
The spike today seems different.
👍️0
Zeppo Zeppo 3 months ago
Vancouver, June 21, 9:00 A.M. Annual Meeting. Now I am waiting to hear where, specifically, it will be held.
👍️0
Zeppo Zeppo 3 months ago
.....better late than never. Like you, however, I ask myself "why now"?
👍️0
ttubular ttubular 3 months ago
It wasn't in any of the others so why now?
👍️0
Zeppo Zeppo 4 months ago
That reference to mergers, etc. on the last page of the 10k is standard as to the inclusion of any "material" reference to a change in ownership.
👍️ 2
ttubular ttubular 4 months ago
$AUPH I went over their 10-K annual filings first time they have put a section in the end about material and non-material info relating to, "a pending or proposed merger, acquisition, tender offer, joint venture, restructuring or change in assets." 
https://www.auriniapharma.com/investors-and-media/sec-filings/all-sec-filings/content/0001600620-24-000041/0001600620-24-000041.pdf 
 
https://www.auriniapharma.com/investors-and-media/sec-filings/all-sec-filings/content/0001600620-25-000011/0001600620-25-000011.pdf
👍️ 2

Your Recent History

NASDAQ
AUPH
Aurinia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads